TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -6 | -11 | -25 | -48 | -65 | -60 | -36 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| S | %ret | 1 | 1 | 1 | 8 | 8 | -6 | -62 | 0 | 0 | -13 |
| S | %wins | 0 | 0 | 100 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/24 16:37 | 1/30/24 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ng George K | MD | DO | CEO | P | 27 | 2.70 | 0 | 10 | 100 | 20 | I | ||||||||||||||
2/28/18 19:04 | 2/28/18 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Ng George K | CA | O | See Rema | P | 896 | 9.95 | 0 | 90 | 28 | 408 | M | ||||||||||||||
2/3/17 19:46 | 2/3/17 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Ng George K | CA | O | See Rema | S | -206 | 5.15 | 1 | -40 | -38 | 64 | D | -48 | 3 | -21 | -6 | -2 | -6 | -3 | -2 | 8 | 8 | -6 | -62 | ||
8/21/15 15:39 | 8/21/15 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Ng George K | CA | O | See Rema | P | 12 | 13.50 | 16 | 1 | 6 | 16 | D | 77 | 151 | 11 | 4 | -19 | -34 | -19 | -16 | -6 | -3 | -15 | -41 | -55 | -52 |
8/5/15 17:00 | 8/3/15 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Ng George K | CA | O | See Rema | P | 132 | 11.50 | 23 | 11 | 332 | 15 | I | 217 | 290 | 109 | 99 | 24 | 13 | -12 | 2 | -6 | -18 | -35 | -54 | -75 | -68 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |